These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38008612)

  • 1. Retraction notice to "In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway" [Biomed. Pharmacother. 95 (2017) 1830-1837].
    Cai QH; Tang Y; Fan SH; Zhang ZF; Li H; Huang SQ; Wu DM; Lu J; Zheng YL
    Biomed Pharmacother; 2023 Dec; 169():115944. PubMed ID: 38008612
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway.
    Cai QH; Tang Y; Fan SH; Zhang ZF; Li H; Huang SQ; Wu DM; Lu J; Zheng YL
    Biomed Pharmacother; 2017 Nov; 95():1830-1837. PubMed ID: 28968927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "Analgesic effects of TLR4/NF-κB signaling pathway inhibition on chronic neuropathic pain in rats following chronic constriction injury of the sciatic nerve" [Biomed. Pharmacother. 107 (2018) 526-533].
    Xu L; Liu Y; Sun Y; Li H; Mi W; Jiang Y
    Biomed Pharmacother; 2023 Jul; 163():114724. PubMed ID: 37087336
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury" [Biomed. Pharmacother. 95 (2017) 885-893].
    Shen M; Wang S; Wen X; Han XR; Wang YJ; Zhou XM; Zhang MH; Wu DM; Lu J; Zheng YL
    Biomed Pharmacother; 2023 Dec; 169():115945. PubMed ID: 38008611
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-κB signaling pathway" [Biomed. Pharmacother. 107 (2018) 1377-1384].
    Li FH; Wang Y; Liu XL; Xu Q
    Biomed Pharmacother; 2023 Aug; 164():114722. PubMed ID: 37087340
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to: "Protective effect of down-regulated microRNA-27a mediating high thoracic epidural block on myocardial ischemia-reperfusion injury in mice through regulating ABCA1 and NF-κB signaling pathway" [Biomed. Pharmacother. 112 (2019) 108606].
    Liu JY; Shang J; Mu XD; Gao ZY
    Biomed Pharmacother; 2023 Sep; 165():114873. PubMed ID: 37353381
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Elevated microRNA-125b promotes inflammation in rheumatoid arthritis by activation of NF-κB pathway" [Biomed. Pharmacother. 93 (2017) 1151-1157].
    Zhang B; Wang LS; Zhou YH
    Biomed Pharmacother; 2022 Jul; 151():112858. PubMed ID: 35341642
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "MicroRNA-19a promotes cell viability and migration of chondrocytes via up-regulating SOX9 through NF-κB pathway" [Biomed. Pharmacother. 98 (2018) 746-753].
    Yu C; Wang Y
    Biomed Pharmacother; 2022 May; 149():112790. PubMed ID: 35282974
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways" [Biomed. Pharmacother. 99 (2018) 451-461].
    Yuan H; Ma J; Li T; Han X
    Biomed Pharmacother; 2022 Jul; 151():112859. PubMed ID: 35341637
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "MicroRNA-30b promotes lipopolysaccharide-induced inflammatory injury and alleviates autophagy through JNK and NF-κB pathways in HK-2 cells" [Biomed. Pharmacother. 101 (2018) 842-851].
    Zhang L; Li J; Cui L; Shang J; Tian F; Wang R; Xing G
    Biomed Pharmacother; 2020 Aug; 128():110279. PubMed ID: 32487440
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to: "microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1" [Biomed. Pharmacother. 113 (2019) 108671].
    Fang H; Li HF; Yang M; Wang RR; Wang QY; Zheng PC; Zhang FX; Zhang JP
    Biomed Pharmacother; 2023 Sep; 165():114874. PubMed ID: 37353383
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway" [Biomed. Pharmacother. 107 (2018) 1744-1753].
    Wang T; Jiang L; Wei X; Liu B; Zhao J; Xie P; Yang B; Wang L
    Biomed Pharmacother; 2023 Apr; 160():114275. PubMed ID: 36725473
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling" [Biomed Pharmacother. 107 (2018) 243-253].
    Liu B; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110635. PubMed ID: 32843235
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Autophagy is a pro-survival mechanism in ovarian cancer against the apoptotic effects of euxanthone" [Biomed. Pharmacother. 103 (2018) 708-718].
    Zhu L; Liu X; Li D; Sun S; Wang Y; Sun X
    Biomed Pharmacother; 2020 Aug; 128():110222. PubMed ID: 32475631
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "The effects of tanshinone IIA on hypoxia/reoxygenation-induced myocardial microvascular endothelial cell apoptosis in rats via the JAK2/STAT3 signaling pathway" [Biomed. Pharmacother. 83 (2016) 1116-1126].
    Cui ZT; Liu JP; Wei WL
    Biomed Pharmacother; 2023 Sep; 165():114749. PubMed ID: 37169677
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "Matrine inhibits hypoxia/reoxygenation-induced apoptosis of cardiac microvascular endothelial cells in rats via the JAK2/STAT3 signaling pathway" [Biomed. Pharmacother. 106 (2018) 117-124].
    Zhao XB; Qin Y; Niu YL; Yang J
    Biomed Pharmacother; 2023 Jun; 162():114721. PubMed ID: 37087339
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling" [Biomed. Pharmacother., vol. 106, October 2018, Pages 483-490].
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2023 Jul; 163():114747. PubMed ID: 37169680
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Betulinic acid protects the neuronal damage in new born rats from isoflurane-induced apoptosis in the developing brain by blocking FASL-FAS signaling pathway" [Biomed. Pharmacother. 95 (2017) 1631-1635].
    Wang D; Chen P; Chen L; Zeng F; Zang R; Liu H; Lu C
    Biomed Pharmacother; 2023 Jul; 163():114748. PubMed ID: 37169676
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Inhibition of PI3K/AKt/mTOR signaling pathway protects against d-galactosamine/lipopolysaccharide-induced acute liver failure by chaperone-mediated autophagy in rats" [Biomed. Pharmacother. 92 (2017) 544-553].
    Li Y; Lu L; Luo N; Wang YQ; Gao HM
    Biomed Pharmacother; 2023 Dec; 169():115943. PubMed ID: 38008613
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p" [Biomed. Pharmacother. 108 (2018) 1022-1028].
    Liu X; Wen J; Wang H; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113354. PubMed ID: 35835664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.